FDA NDC Directory · JSON-LD · Markdown

Halaven

NDC 62856-389 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameeribulin mesylate
Labeler / ManufacturerEisai Inc.
Marketing categoryNew Drug Application (innovator) · App NDA201532
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsERIBULIN MESYLATE (.5 mg/mL)
Marketing started20101115
Package count1

External sources

Source: openFDA. Public-domain (CC0).